Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) ROCE % : 4.81% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 4.81%.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROCE % Historical Data

The historical data trend for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROCE % Chart

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

13.22

11.07

11.06

5.19

5.86

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															3.50	8.84	6.52	4.99	4.81

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROCE % Calculation

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	58.36	/	( ( (1017.003 - 38.736)	+	(1067.196 - 53.698) )	/ 2 )
	=	58.36	/	( (978.267	+	1013.498)	/ 2 )
	=	58.36	/	995.8825
	=	5.86 %

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	44.488	/	( ( (966.153 - 43.718)	+	(976.929 - 50.62) )	/ 2 )
	=	44.488	/	( ( 922.435	+	926.309 )	/ 2 )
	=	44.488	/	924.372
	=	4.81 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROCE % Related Terms

Thank you for viewing the detailed overview of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd (SZSE:301130) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province, Panshi, CHN, 132300

Website

http://www.xidianyy.com

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Headlines

No Headlines